YM4-10202-56424
3 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 941 / CA
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-31
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-01-21
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
-
2021-02-04
Survey response — day 14, dose 2MedDRA: Chills, Fatigue, Headache, Pain — Feeling: GoodFree text: On Friday, Saturday, and Sunday I was fatigued, had mild body aches, and mild chills. I also had a headache that lasted throughout those days as well. However, the symptoms decreased and I have felt great since Monday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
- 2021-02-26
- 2021-03-04
- 2021-04-22
- 2021-07-22
-
2021-10-18
Dose 3 — Pfizer-BioNTech
- 2022-01-21
-
2022-10-18
Survey response — 12 months, dose 3MedDRA: Fatigue, Migraine, Pain, Respiratory disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Migraines, body aches, fatigue, increased breathing challengesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-18
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-10-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-18 | Unsuccessful |
Free text
Release 3 — day 14, dose 2
Symptoms: On Friday, Saturday, and Sunday I was fatigued, had mild body aches, and mild chills. I also had a headache that lasted throughout those days as well. However, the symptoms decreased and I have felt great since Monday.
Release 12 — 12 months, dose 3
Symptoms: Migraines, body aches, fatigue, increased breathing challenges
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release